Form 4 for AMPX Amprius Technologies, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001942459-24-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-21 | AMPX | Bornstein Jonathan | Pres of Amprius Lab | S - Sale | $1.96 | -18.2K | 454.1K | -4% | -$35.6K | |
| MI | 2024-11-22 | 2024-11-20+ | AMPX | Bornstein Jonathan | Pres of Amprius Lab | S - Sale | $1.92 | -148.5K | 1.04M | -13% | -$285.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-11-21 | S | D | 18,170 | $1.96 | 454,131 | D | — | — | (F7) The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.93 to $2.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F8) These securities are restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. |
| 2 | Common | Common stock | 2024-11-21 | S | D | 15,000 | $1.96 | 1,040,950 | I See Footnote | — | — | (F4) The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.92 to $2.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F5) Includes 16,763 shares of the issuer's common stock previously held directly by the reporting person, which were transferred on November 21, 2024 to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees. (F3) The securities are held directly by Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees. |
| 3 | Common | Common stock | 2024-11-20 | S | D | 133,536 | $1.92 | 1,039,187 | I See Footnote | — | — | (F1) The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.89 to $1.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) These shares of the issuer's common stock, which were previously held directly by the reporting person, were transferred on September 30, 2024 to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees. (F3) The securities are held directly by Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees. |